Corcept Therapeutics (CORT) is down -7.8%, or -$6.81 to $80.49.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics initiated with a Neutral at UBS
- Hold Rating for Corcept Therapeutics Amid Limited Upside and Market Challenges
- 3 ‘Strong Buy’ Stocks to Buy Today, 12/9/2025, According to Top Analysts
- 3 ‘Strong Buy’ Stocks Backed by Technical Analysis
- Corcept Therapeutics: Poised for Growth with Relacorilant’s Launch and Strong Market Positioning